141 related articles for article (PubMed ID: 10669174)
1. Is there a role for anti-phospholipid-binding protein antibodies in the pathogenesis of thrombosis in Behcet's disease?
Priori R; Conti F; Pittoni V; Garofalo T; Sorice M; Valesini G
Thromb Haemost; 2000 Jan; 83(1):173-4. PubMed ID: 10669174
[No Abstract] [Full Text] [Related]
2. Revisiting antiphospholipid antibodies: from targeting phospholipids to phospholipid binding proteins.
Bertolaccini ML; Hughes GR; Khamashta MA
Clin Lab; 2004; 50(11-12):653-65. PubMed ID: 15575307
[TBL] [Abstract][Full Text] [Related]
3. [Antiphospholipid antibodies: clinical significance and biological diagnosis].
Arnoux D; Boutière B; Sanmarco M
Ann Biol Clin (Paris); 2000; 58(5):557-74. PubMed ID: 11022099
[TBL] [Abstract][Full Text] [Related]
4. [Association between anti-phospholipid antibodies and thrombotic complications in systemic lupus erythematosus].
Nojima J
Rinsho Byori; 2003 Mar; 51(3):239-47. PubMed ID: 12707997
[TBL] [Abstract][Full Text] [Related]
5. Antiannexin V autoantibody in thrombophilic Behçet's disease.
Aslan H; Pay S; Gok F; Baykal Y; Yilmaz MI; Sengul A; Aydin HI
Rheumatol Int; 2004 Mar; 24(2):77-9. PubMed ID: 14658002
[TBL] [Abstract][Full Text] [Related]
6. Distinguishing features of anti-beta2 glycoprotein I antibodies between patients with leprosy and the antiphospholipid syndrome.
Arvieux J; Renaudineau Y; Mane I; Perraut R; Krilis SA; Youinou P
Thromb Haemost; 2002 Apr; 87(4):599-605. PubMed ID: 12008941
[TBL] [Abstract][Full Text] [Related]
7. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
8. Specificity of anti-phospholipid antibodies in infectious mononucleosis: a role for anti-cofactor protein antibodies.
Sorice M; Pittoni V; Griggi T; Losardo A; Leri O; Magno MS; Misasi R; Valesini G
Clin Exp Immunol; 2000 May; 120(2):301-6. PubMed ID: 10792380
[TBL] [Abstract][Full Text] [Related]
9. Antiprothrombin and antiannexin V antibodies imply risk of thrombosis in patients with systemic autoimmune diseases.
Lakos G; Kiss E; Regeczy N; Tarjan P; Soltesz P; Zeher M; Bodolay E; Szucs G; Szakony S; Sipka S; Szegedi G
J Rheumatol; 2000 Apr; 27(4):924-9. PubMed ID: 10782817
[TBL] [Abstract][Full Text] [Related]
10. Activated protein C resistance and lupus anticoagulant activity induced by plasma and purified monospecific human IgG anti-beta2-glycoprotein-I antibodies.
Viveros ME; Cabiedes J; Reyes E; Cabral AR
Rev Invest Clin; 2005; 57(4):563-71. PubMed ID: 16315641
[TBL] [Abstract][Full Text] [Related]
11. High prevalence of anti-prothrombin antibody in patients with deep vein thrombosis.
Ishikura K; Wada H; Kamikura Y; Hattori K; Fukuzawa T; Yamada N; Nakamura M; Nobori T; Nakano T
Am J Hematol; 2004 Aug; 76(4):338-42. PubMed ID: 15282665
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies to phospholipid-binding plasma proteins: a new view of lupus anticoagulants and other "antiphospholipid" autoantibodies.
Roubey RA
Blood; 1994 Nov; 84(9):2854-67. PubMed ID: 7949161
[No Abstract] [Full Text] [Related]
13. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
[TBL] [Abstract][Full Text] [Related]
14. Identification of thrombin antibodies in patients with antiphospholipid syndrome.
Miesbach W; Matthias T; Scharrer I
Ann N Y Acad Sci; 2005 Jun; 1050():250-6. PubMed ID: 16014540
[TBL] [Abstract][Full Text] [Related]
15. Pathogenic role of antiprotein-phospholipid antibodies.
Carreras LO; Forastiero RR
Haemostasis; 1996 Oct; 26 Suppl 4():340-57. PubMed ID: 8979139
[TBL] [Abstract][Full Text] [Related]
16. Antiphospholipid antibody tests: spreading the net.
Bertolaccini ML; Gomez S; Pareja JF; Theodoridou A; Sanna G; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Nov; 64(11):1639-43. PubMed ID: 15817655
[TBL] [Abstract][Full Text] [Related]
17. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
18. Antibodies to beta2-glycoprotein I in anticardiolipin negative patients.
Picillo U; Marcialis MR; Italiano G
J Rheumatol; 1998 Jul; 25(7):1440-2. PubMed ID: 9676785
[No Abstract] [Full Text] [Related]
19. Anti-prothrombin but not "pure" anti-cardiolipin antibodies are associated with the clinical features of the antiphospholipid antibody syndrome.
Sorice M; Pittoni V; Circella A; Misasi R; Conti F; Longo A; Pontieri GM; Valesini G
Thromb Haemost; 1998 Oct; 80(4):713-5. PubMed ID: 9799003
[No Abstract] [Full Text] [Related]
20. The association of antibodies to cardiolipin, beta 2-glycoprotein I, prothrombin, and oxidized low-density lipoprotein with thrombosis in 292 patients with familial and sporadic systemic lupus erythematosus.
Koskenmies S; Vaarala O; Widen E; Kere J; Palosuo T; Julkunen H
Scand J Rheumatol; 2004; 33(4):246-52. PubMed ID: 15370721
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]